Group 1 - Lindt & Spruengli reported that chocolate sales are increasing among U.S. users of GLP-1 weight-loss drugs, contrary to expectations that these drugs would decrease confectionery demand [1] - An internal study indicated that 15% of U.S. households use GLP-1s, which account for 17.5% of chocolate sales [1] - U.S. sales of premium chocolate among GLP-1 users rose by nearly 17% in 2025, compared to a 6.5% increase among non-GLP-1 users [1] Group 2 - Analysts at Berenberg had predicted that the introduction of oral GLP-1 weight-loss drugs would negatively impact the food industry, particularly confectionery, estimating a sales volume drag of 0.9 percentage points for Lindt by 2027 [1] - The anticipated expansion of GLP-1 drug usage is expected to include more men and younger patients, as oral drugs are projected to result in less drastic weight loss compared to injectables [1]